- Home
- AVIR vs NIU Comparison
AVIR vs NIU Comparison
Compare AVIR & NIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- NIU
- Stock Information
- Founded
- AVIR 2012
- NIU 2014
- Country
- AVIR United States
- NIU China
- Employees
- AVIR N/A
- NIU N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- NIU Auto Manufacturing
- Sector
- AVIR Health Care
- NIU Consumer Discretionary
- Exchange
- AVIR Nasdaq
- NIU Nasdaq
- Market Cap
- AVIR 277.8M
- NIU 275.6M
- IPO Year
- AVIR 2020
- NIU 2018
- Fundamental
- Price
- AVIR $3.50
- NIU $4.99
- Analyst Decision
- AVIR Hold
- NIU
- Analyst Count
- AVIR 1
- NIU 0
- Target Price
- AVIR $6.00
- NIU N/A
- AVG Volume (30 Days)
- AVIR 361.0K
- NIU 873.5K
- Earning Date
- AVIR 08-07-2025
- NIU 08-11-2025
- Dividend Yield
- AVIR N/A
- NIU N/A
- EPS Growth
- AVIR N/A
- NIU N/A
- EPS
- AVIR N/A
- NIU N/A
- Revenue
- AVIR N/A
- NIU $527,760,629.00
- Revenue This Year
- AVIR N/A
- NIU $41.32
- Revenue Next Year
- AVIR N/A
- NIU $24.38
- P/E Ratio
- AVIR N/A
- NIU N/A
- Revenue Growth
- AVIR N/A
- NIU 32.62
- 52 Week Low
- AVIR $2.46
- NIU $1.66
- 52 Week High
- AVIR $4.15
- NIU $5.37
- Technical
- Relative Strength Index (RSI)
- AVIR 48.71
- NIU 79.79
- Support Level
- AVIR $3.33
- NIU $3.41
- Resistance Level
- AVIR $3.60
- NIU $4.57
- Average True Range (ATR)
- AVIR 0.16
- NIU 0.30
- MACD
- AVIR -0.02
- NIU 0.15
- Stochastic Oscillator
- AVIR 26.69
- NIU 80.61
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About NIU Niu Technologies
Niu Technologies designs, manufactures and sells high-performance electric motorcycles, scooters, bicycles, and kick-scooters. The company has a product portfolio consisting of electric motorcycle, mopeds and bicycle series, including the NQi, MQi, UQi, F series, and others, and micro-mobility series, including the kick-scooter series KQi and the e-bike series BQi. The company's principal operations and geographic markets are predominantly in the People's Republic of China. It also generates revenue from Europe and other regions.